Summary
64 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 48% a year over the last 3 years.
- Out of every 100 USD of revenue, 172 USD is left as net profit.
- It bought back its own shares for $241.1M in the last fiscal year, 4.4% of its market value.
What to watch
- Revenue fell by 12% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 11.5 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 24% a year over 5 years. Over the last 3 years it fell by 12% a year. Earnings per share grew by 48% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 30 USD
- Sales and administration -104 USD
- Taxes and other 0.8 USD
- Net profit 172 USD
Net profit, industry median (Asset Management) 34 USD
Out of every 100 USD of revenue, 172 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.39%
- Paid out of profit
- 4.5%
You receive $0.29 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.